Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Can routine outpatient follow-up of patients with bladder cancer be improved? A multicenter prospective observational assessment of blue light flexible cystoscopy and fulguration

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Intralesional and Mechanical Therapies for Peyronie's Disease: A Road Anything but Straight

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Are We Ready for Active Surveillance for Clinical Stage IS Testicular Cancer?

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Complex Polygenic Nature of Testicular Germ Cell Cancer Suggests Multifactorial Aetiology

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  1. National incidence and survival of patients with non-invasive papillary urothelial carcinoma: a Danish population study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Moving treatment of Ta low grade bladder tumors from the operating theatre to the outpatient depart-ment

    Publikation: KonferencebidragKonferenceabstrakt til konferenceForskningpeer review

Vis graf over relationer

Background: The aim of this prospective cohort study was to determine the feasibility of incorporating blue light flexible cystoscopy (BLFC) and biopsy/fulguration into routine outpatient follow-up of non-muscle invasive bladder cancer patients.

Methods: The study included patients with non-muscle-invasive bladder cancer (NMIBC) who were scheduled for routine follow-up. Hexaminolevulinate was instilled in the outpatient department, and the bladder was examined under white light and then with BLFC. Biopsies were taken from all suspicious lesions. Small tumors and suspicious lesions were fulgurated on site; patients with larger lesions were referred to the operating room for resection.

Results: The study included 69 patients, with a mean age of 70 years (range 33-89 years) and a mean duration since NMIBC diagnosis of 8 years. Most patients had high-grade cancer at initial diagnosis (52/69) and were at high risk of recurrence (48/69). Two patients per hour could be assessed using outpatient BLFC. Preparation and instillation of hexaminolevulinate took less than 10 minutes per patient, and patients had an additional waiting time of 45-60 minutes following instillation, while the hexaminolevulinate solution was retained in the bladder before examination. Eleven patients had histologically confirmed tumors that were identified using both white light flexible cystoscopy and BLFC. An additional three patients had tumors that were identified by BLFC only: two with Ta tumors and one with carcinoma in situ. Of the 14 patients with confirmed tumors, 11 could be managed on site with fulguration, whereas three were referred to the operating room. No adverse events attributable to BLFC were reported.

Conclusion: Routine outpatient management of patients with NMIBC using BLFC and on-site biopsy/fulguration is feasible, despite the additional time required for hexaminolevulinate instillation, and appears to allow early detection of recurrent lesions, which can be fulgurated without the need for hospitalization.

OriginalsprogEngelsk
TidsskriftEuropean Urology
Vol/bind10
Sider (fra-til)151-157
Antal sider7
ISSN2253-2447
DOI
StatusUdgivet - 9 okt. 2018

ID: 55530068